{"id":"W2913793077","doi":"10.1007/s11938-019-00222-9","title":"Advances in Therapeutic Drug Monitoring for Small-Molecule and Biologic Therapies in Inflammatory Bowel Disease","year":2019,"lang":"en","type":"review","venue":"Current Treatment Options in Gastroenterology","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":43,"is_retracted":false,"has_abstract":false,"ca_institutions":"Western University; Robarts Clinical Trials; University of Calgary","funders":"","keywords":"Vedolizumab; Medicine; Therapeutic drug monitoring; Tofacitinib; Ustekinumab; Inflammatory bowel disease; Drug; Intensive care medicine; Infliximab; Pharmacology; Disease; Internal medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001928912,0.0005784333,0.0007534645,0.0004531486,0.0000442643,0.00002729263,0.0002587973,0.0001961731,0.000002835476],"category_scores_gemma":[0.00002780444,0.0004921035,0.0002965913,0.00008186683,0.000150741,0.00001456695,0.0001208446,0.0002004068,0.000005262903],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00027934,"about_ca_system_score_gemma":0.0001911853,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000002391667,"about_ca_topic_score_gemma":0.0002094278,"domain_scores_codex":[0.9974158,0.000463898,0.0006490776,0.0008331386,0.00006177556,0.0005762955],"domain_scores_gemma":[0.9991052,0.00005509562,0.0002307077,0.0004725874,0.00002813131,0.0001082716],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0008137692,0.0009504154,0.8031138,0.005245113,0.0001481228,0.00007040598,0.00008546632,0.0002216638,0.0000179496,0.0001949236,0.000004367795,0.189134],"study_design_scores_gemma":[0.02071972,0.002995909,0.5467488,0.01668799,0.001754228,0.00005492874,0.0004679332,0.0002576731,0.00001145239,0.0007642571,0.4069368,0.002600343],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.195653,0.8018101,0.0000537974,0.00001431314,0.0004555277,0.001876477,0.0001193687,0.00001188102,0.000005565887],"genre_scores_gemma":[0.03532395,0.9607848,0.00008064623,0.00001159733,0.0001321295,0.003111353,0.0004814221,0.00005100877,0.00002307737],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.4069324,"threshold_uncertainty_score":0.9997531,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04150820438250586,"score_gpt":0.3372733203136206,"score_spread":0.2957651159311147,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}